Category: PrimeCuts

Commentary By: Joshua Olstein, MD Associate Editor, Clinical Correlations

Let’s begin this week by congratulating the Superbowl XLII champion New York Giants on an excellent victory. As Americans wakes up the day after and begin to recover from …

Commentary by Henry Tran, MD

Old adage: just because it’s new doesn’t necessarily mean it’s better. The FDA approved the usage of drug-eluting stents (DES) in 2003 and these stents were quickly embraced by …

Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations

If you think the modern scientific literature is reading more and more like science fiction each day, get a load of this: apparently they are …

Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations

Published in the NEJM this week was a study intended to conclusively determine whether corticosteroids are an effective adjunctive therapy in severe sepsis. Although corticosteroid …

Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program

This week’s Annals of Internal Medicine focused on angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB). Two studies addressed …

Commentary by Michael Poles MD, Associate Editor, Clinical Correlations 

Another week, another set of shortcuts, so let’s take a quick look around the world of medical happenings. A quick trip into the strange. The …

Commentary By: Neil Shapiro, M.D., Editor-In-Chief, Clinical Correlations

It’s hard to believe there was other news this week besides the black cloud that has now been cast over all of baseball.  Barry Bonds …

Commentary By: Sean Cavanaugh, M.D. Associate Editor Clinical Correlations

Science magazine published the first practical application of the induced pluripotent stem (IPS) cells in a mouse model for sickle cell anemia. As was recently published, skin cells can be transformed …